Skip to main content
x

FDA Approves First U.S. Vaccine for Humans Against the Avian Influenza Virus H5N1

Rating
The vaccine could be used in the event the current H5N1 avian virus were to develop the capability to efficiently spread from human to human, resulting in the rapid spread of the disease across the globe. Should such an influenza pandemic emerge, the vaccine may provide early limited protection in the months before a vaccine tailored to the pandemic strain of the virus could be developed and produced